Shuttle Pharmaceuticals, Inc.

This study tested whether adding an oral medication called ropidoxuridine to standard radiation treatment could better control an aggressive type of brain cancer called glioblastoma. The trial involved 30 adults with newly diagnosed tumors that are typically resistant to standard…